Balchem Quarterly Income Statement
NASDAQ: BCPCIndustrialsMajor ChemicalsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Balchem revenue and earnings
In the quarter ended Jun 30, 2026, Balchem generated $284.0 million in revenue, up 11.2% from the same quarter a year earlier. Net income was $44.6 million (+16.6% year over year), for a net margin of 15.7% versus a median of 14.9% in the prior 5 quarters. Gross margin was 36.5% (up from 36.4%) and operating margin 20.9%.
Diluted earnings per share came in at $1.39, up from $1.17.
Summary generated from market data by MetaCap's automated system. Methodology
Balchem income statement (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 284.00M | 270.71M | 263.62M | 267.56M | 255.47M | 250.52M | 240.00M | 239.94M | 234.08M | 239.66M | 228.70M | 229.95M |
| Revenue growth (YoY) | +11.17% | +8.06% | +9.84% | +11.51% | +9.14% | +4.53% | +4.94% | +4.35% | +1.22% | +3.06% | -1.65% | -5.86% |
| Cost of Revenue | 180.31M | 169.63M | 169.72M | 172.10M | 162.35M | 162.35M | 153.67M | 154.58M | 151.09M | 158.15M | 153.71M | 153.40M |
| Gross Profit | 103.68M | 101.08M | 93.90M | 95.45M | 93.11M | 88.17M | 86.34M | 85.36M | 82.99M | 81.51M | 74.99M | 76.54M |
| Operating Expenses | 44.46M | 45.46M | 41.61M | 40.87M | 41.67M | 37.15M | 38.89M | 37.37M | 37.20M | 39.84M | 36.66M | 32.93M |
| Research & Development | 4.53M | 5.88M | 5.05M | 4.50M | 4.30M | 4.66M | 4.51M | 4.33M | 3.85M | 4.10M | 3.94M | 3.87M |
| Selling, General & Admin | 39.93M | 39.58M | 36.56M | 36.38M | 37.37M | 32.49M | 34.38M | 33.04M | 33.34M | 35.74M | 32.72M | 29.06M |
| Operating Income | 59.22M | 55.63M | 52.29M | 54.58M | 51.44M | 51.02M | 47.44M | 47.99M | 45.80M | 41.68M | 38.34M | 43.61M |
| Other Income (Expense) | -1.44M | -3.10M | -2.25M | -2.54M | -2.43M | -3.08M | -2.96M | -4.10M | -4.57M | -4.83M | -5.07M | -7.14M |
| Pretax Income | 57.78M | 52.52M | 50.03M | 52.04M | 49.01M | 47.94M | 44.48M | 43.89M | 41.23M | 36.85M | 33.27M | 36.48M |
| Income Tax | 13.17M | 12.24M | 10.81M | 11.76M | 10.73M | 10.89M | 10.90M | 10.06M | 9.16M | 7.86M | 6.62M | 7.40M |
| Net Income | 44.62M | 40.28M | 39.23M | 40.29M | 38.28M | 37.05M | 33.58M | 33.84M | 32.07M | 28.99M | 26.65M | 29.07M |
| Net Income growth (YoY) | +16.56% | +8.72% | +16.80% | +19.07% | +19.36% | +27.83% | +26.02% | +16.38% | +6.51% | +27.64% | +24.49% | +15.15% |
| EPS (Basic) | 1.40 | 1.26 | 1.23 | 1.25 | 1.18 | 1.14 | 1.05 | 1.05 | 0.99 | 0.90 | 0.83 | 0.91 |
| EPS (Diluted) | 1.39 | 1.25 | 1.21 | 1.24 | 1.17 | 1.13 | 1.03 | 1.03 | 0.98 | 0.89 | 0.82 | 0.90 |
| Shares Outstanding (Basic) | 31.90M | 31.94M | — | 32.27M | 32.35M | 32.44M | — | 32.37M | 32.31M | 32.25M | — | 32.12M |
| Shares Outstanding (Diluted) | 32.20M | 32.28M | — | 32.59M | 32.68M | 32.81M | — | 32.78M | 32.65M | 32.63M | — | 32.48M |
| EBITDA | 71.44M | 68.12M | 64.01M | 66.13M | 62.84M | 62.03M | 58.34M | 58.90M | 58.30M | 55.34M | 52.39M | 57.42M |
| Gross Margin | 36.51% | 37.34% | 35.62% | 35.68% | 36.45% | 35.19% | 35.97% | 35.58% | 35.46% | 34.01% | 32.79% | 33.29% |
| Operating Margin | 20.85% | 20.55% | 19.84% | 20.40% | 20.14% | 20.36% | 19.77% | 20.00% | 19.56% | 17.39% | 16.76% | 18.97% |
| Net Margin | 15.71% | 14.88% | 14.88% | 15.06% | 14.98% | 14.79% | 13.99% | 14.10% | 13.70% | 12.09% | 11.65% | 12.64% |
This table shows 12 quarterly periods of Balchem's income statement, from Q2 2026 back to Q3 2023, across 20 line items including revenue, cost of revenue, gross profit. Values in USD; B = billions, M = millions. Fiscal periods follow BCPC's reporting calendar. What is a income statement?